Evidence map›Paper›PMID 38077031›Full record

ArticleResearch square2023

Proximal immune-epithelial progenitor interactions drive chronic tissue sequelae post COVID-19.

Harish Narasimhan, In Su Cheon, Wei Qian, Sheng'en Hu, Tanyalak Parimon, Chaofan Li, Nick Goplen, Yue Wu, Xiaoqin Wei, Young Min Son and 20 more

Open access · greenAbstract readPreprint
In one paragraph

Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. How calorie restriction slows aging: an epigenetic perspective.Journal of molecular medicine (Berlin, Germany) · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors at 6 institutions in 2 countries.

Harish NarasimhanBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
In Su CheonBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Wei QianBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Sheng'en HuCenter for Public Health Genomics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Tanyalak ParimonWomen's Guild Lung Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Chaofan LiBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.ORCID 0000-0002-5426-1498
Nick GoplenRobert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0003-4614-5996
Yue WuBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.ORCID 0000-0003-3667-2960
Xiaoqin WeiBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Young Min SonDepartment of Systems Biotechnology, Chung-Ang University, Anseong, Korea.
Elizabeth FinkBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Gislane SantosBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Jinyi TangBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Changfu YaoWomen's Guild Lung Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.ORCID 0000-0003-1357-5017
Lyndsey MuehlingDivision of Asthma, Allergy and Immunology, Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Glenda CanderanDivision of Asthma, Allergy and Immunology, Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Alexandra KadlDivision of Pulmonary and Critical Care Medicine, Department of medicine, University of Virginia, Charlottesville, VA 22908, USA.
Abigail CannonBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Samuel YoungBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Riley HannanDivision of Pulmonary and Critical Care Medicine, Department of medicine, University of Virginia, Charlottesville, VA 22908, USA.
Grace BinghamDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA 22908, USA.
Mohammed ArishBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Arka Sen ChaudhariBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.
Jeffrey SturekDivision of Pulmonary and Critical Care Medicine, Department of medicine, University of Virginia, Charlottesville, VA 22908, USA.
Patcharin PramoonjagoSchool of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Yun Michael ShimDivision of Pulmonary and Critical Care Medicine, Department of medicine, University of Virginia, Charlottesville, VA 22908, USA.
Judith WoodfolkDivision of Asthma, Allergy and Immunology, Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Chongzhi ZangCenter for Public Health Genomics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.ORCID 0000-0003-4812-3627
Peter ChenWomen's Guild Lung Institute, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Jie SunBeirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908, USA.ORCID 0000-0002-2347-4511
Carter Center · USUniversity of Virginia · USAsthma and Allergy Specialists · USCedars-Sinai Medical Center · USChung-Ang University · KRWinnMed · US

Funding

Cancer Research Training Program: From Molecular Mechanisms to Therapeutic StrategiesT32CA009109 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Andrew Carl Dudley, Melanie R Rutkowski · 1985 to 2026
$13.9M
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGYT32AI007496 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Michael G. Brown, Coleen A McNamara · 1995 to 2026
$10.2M
Host cellular network governing the development of post SARS-CoV-2 tissue sequelaeR01AI147394 · NIAID · UNIVERSITY OF VIRGINIA · PI Jie Sun · 2020 to 2026
$4.7M
Molecular regulation of protective CD8 immunity against influenza infectionR01AI112844 · NIAID · UNIVERSITY OF VIRGINIA · PI SUN, JIE · 2015 to 2024
$4.5M
Hyperpolarized Xenon-129 MRI: a new multi-dimensional biomarker to determine pulmonary physiologic responses to COPD therapeuticsR01HL132177 · NHLBI · UNIVERSITY OF VIRGINIA · PI QING, KUN, SHIM, YUN MICHAEL · 2017 to 2021
$3.9M
Elucidating the roles of alveolar macrophage inflammation and selfrenewal during influenza infectionR01AG069264 · NIA · UNIVERSITY OF VIRGINIA · PI Jie Sun · 2020 to 2026
$3.5M
Sexual dimorphism in susceptibility to emphysematous tissue injuryR01HL167202 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI ANI Wang MANICHAIKUL, Yun Michael Shim · 2023 to 2026
$3.0M
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfectionR01AI154598 · NIAID · UNIVERSITY OF VIRGINIA · PI SUN, JIE · 2020 to 2024
$2.9M
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with AsthmaR01AI176171 · NIAID · UNIVERSITY OF VIRGINIA · PI Jie Sun, WILLIAM GERALD TEAGUE · 2023 to 2026
$2.7M
Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19R01HL170961 · NHLBI · UNIVERSITY OF VIRGINIA · PI Jie Sun, ROBERT VASSALLO · 2023 to 2026
$2.7M
Discovery of New Anti-Inflammatory Agents to Treat COPDR01HL132287 · NHLBI · GEORGE MASON UNIVERSITY · PI NOBLE, SCHROEDER M, PAIGE, MIKELL · 2016 to 2019
$2.4M
Fungal dysbiosis regulation of post-influenza bacterial pneumoniaR01HL155759 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI CHEN, PETER · 2021 to 2024
$2.4M
NCI NIH HHS T32 CA009109NHLBI NIH HHS F31 HL170746NHLBI NIH HHS K08 HL091127NHLBI NIH HHS R01 HL132177NHLBI NIH HHS R01 HL132287NHLBI NIH HHS R01 HL155759NHLBI NIH HHS R01 HL167202NHLBI NIH HHS R01 HL170961NIAID NIH HHS R01 AI112844NIAID NIH HHS R01 AI147394NIAID NIH HHS R01 AI154598NIAID NIH HHS R01 AI176171NIAID NIH HHS T32 AI007496NIA NIH HHS R01 AG069264
6 · The paper itself

Abstract

The long-term physiological consequences of SARS-CoV-2, termed Post-Acute Sequelae of COVID-19 (PASC), are rapidly evolving into a major public health concern. The underlying cellular and molecular etiology remain poorly defined but growing evidence links PASC to abnormal immune responses and/or poor organ recovery post-infection. Yet, the precise mechanisms driving non-resolving inflammation and impaired tissue repair in the context of PASC remain unclear. With insights from three independent clinical cohorts of PASC patients with abnormal lung function and/or viral infection-mediated pulmonary fibrosis, we established a clinically relevant mouse model of post-viral lung sequelae to investigate the pathophysiology of respiratory PASC. By employing a combination of spatial transcriptomics and imaging, we identified dysregulated proximal interactions between immune cells and epithelial progenitors unique to the fibroproliferation in respiratory PASC but not acute COVID-19 or idiopathic pulmonary fibrosis (IPF). Specifically, we found a central role for lung-resident CD8

Identifiers

PMID38077031
PMCPMC10705705
OpenAlexW4389068381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.